Japan’s Dentsu Ventures invests in laboratory-in-a-box maker Cue
Cue's cube-shaped hardware accepts proprietary diagnostic cartridges to provide easy at-home analysis of healthcare data at the molecular level.
Cue secures $7.5 Million in Series A funding
The company makes the technology that enables users to connect to their wellness at the molecular level, allowing for a deeper level of health tracking.
Cue’s $199 lab-in-a-box could replace lab tests, trips to a doctor’s office
The product comes in the form of a small cubic kit that can analyze anything from a swab of saliva to blood, to discern what's going on in your body.